Saccomano Nicholas A

President and CEO at OKUR; CSO at ARRAY BIOPHARMA INC

Sold, on record
$4M
Dollars the filings state
Form 4 sales
8
Latest Sep 21, 2026
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
4
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale ARRAY BIOPHARMA INCUnusual
    Feb 7, 2019 2019

    Sold 187,264 shares at $21.58 ($4M)

    Saccomano Nicholas A, CSO

    Sold 56.8% of holdings ($7.1M position)142,488 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale OKURNo plan
    Apr 7, 2025 +2251 days

    Sold 874 shares at $2.94 ($3k)

    Saccomano Nicholas A, President and CEO

    No 10b5-1 planSold 19.2% of holdings ($13k position)3,682 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale OKURNo plan
    Jun 23, 2025 +77 days

    Sold 88 shares at $2.38 ($209)

    Saccomano Nicholas A, President and CEO

    No 10b5-1 planSold 2.4% of holdings ($9k position)3,594 shares leftFiling

  4. 4 Form 4 sale OKURNo plan
    Sep 22, 2025 +91 days

    Sold 88 shares at $2.62 ($231)

    Saccomano Nicholas A, President and CEO

    No 10b5-1 planSold 2.4% of holdings ($9k position)3,506 shares leftFiling

  5. 5 Form 4 sale OKURNo plan
    Dec 22, 2025 +91 days

    Sold 87 shares at $2.97 ($258)

    Saccomano Nicholas A, President and CEO

    No 10b5-1 planSold 1.2% of holdings ($22k position)7,419 shares left1x usual sizeFiling

  6. 6 Form 4 sale OKURNo plan
    Mar 23, 2026 +91 days

    Sold 86 shares at $4.16 ($358)

    Saccomano Nicholas A, President and CEO

    No 10b5-1 planSold 1.2% of holdings ($31k position)7,333 shares left1x usual sizeFiling

  7. 7 Form 4 sale OKURNo plan
    Jun 22, 2026 +91 days

    Sold 86 shares at $4.40 ($378)

    Saccomano Nicholas A, President and CEO

    No 10b5-1 planSold 0.8% of holdings ($50k position)11,247 shares left1x usual sizeFiling

  8. 8 Form 4 sale OKURNo plan
    Sep 21, 2026 +91 days

    Sold 87 shares at $2.97 ($258)

    Saccomano Nicholas A, President and CEO

    No 10b5-1 planSold 0.8% of holdings ($33k position)11,160 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Saccomano Nicholas A
Source
Sep 21, 2026Sep 23, 2026OKURPresident and CEOForm 4 sale87$2580.8%No planSEC
Jun 22, 2026Jun 24, 2026OKURPresident and CEOForm 4 sale86$3780.8%No planSEC
Mar 23, 2026Mar 24, 2026OKURPresident and CEOForm 4 sale86$3581.2%No planSEC
Dec 22, 2025Dec 23, 2025OKURPresident and CEOForm 4 sale87$2581.2%No planSEC
Sep 22, 2025Sep 24, 2025OKURPresident and CEOForm 4 sale88$2312.4%No planSEC
Jun 23, 2025Jun 25, 2025OKURPresident and CEOForm 4 sale88$2092.4%No planSEC
Apr 7, 2025Apr 8, 2025OKURPresident and CEOForm 4 sale874$3k19.2%No planSEC
Feb 7, 2019Feb 8, 2019ARRAY BIOPHARMA INCCSOForm 4 sale187,264$4M56.8%UnusualSEC